This is a well-established medical cannabis card consulting business with 8 years of proven operations. The company specializes in patient consultations and issuance of medical cannabis cards, with a streamlined renewal process every seven months conducted conveniently over the phone.

Key Highlights for Buyers

•  Strong Market Growth – Located in a rapidly expanding geographic area with very limited competition.
•  Legislative Tailwinds – Recent legislation banning intoxicating hemp products is expected to significantly boost demand for medical cannabis cards.
•  Low Liability Model – Patients are required to have a diagnosis from an outside physician prior to consultation, minimizing risk and liability for the business and doctor.
•  Recurring Revenue Stream – Mandatory 7-month renewals ensure consistent, predictable income.
•  Established Reputation – Trusted provider with nearly a decade of experience in the medical cannabis space.

Why Invest?
This business is uniquely positioned to capitalize on legislative changes and demographic growth in the area. With minimal competition, a recurring revenue model, and strong patient demand, it offers an attractive opportunity for buyers seeking entry into the medical cannabis industry with reduced risk and high upside potential.

Contact Tom Jones at 754-224-3111, refer to 8940-799918 when inquiring.

As the only independent retail store that accepts over-the counter insurance cards, this store stands out by offering many competitive purchasing advantages. It’s prime location in a bustling strip mall guaranteeing high visibility, attracting a loyal and diverse customer base.

The store is known for it’s friendly atmosphere and a knowledgeable, experienced staff committed to providing top-notch service. With an extensive inventory that caters to the needs of health-conscious consumers, this business is poised for continued growth and success.

Don’t miss your chance to take over this well-established health food store and continue its legacy of promoting health and wellness in the community. NDA and Profile required highly confidential listing.

Contact Tom Jones at 754-224-3111, refer to 924-28132 when inquiring.

The business operates under full regulatory compliance with the FDA, DEA, Department of Health, and PDPR, ensuring the safety, traceability, and quality of all distributed products. Licensed to operate in nine U.S. states, it serves a broad client base of more than 5,000 hospitals, private clinics, pharmacies, and institutional healthcare organizations.

The company has a wholesale license to operate in the following states: Pennsylvania, New York, New Jersey, Tennessee, Georgia, Michigan, Texas, Kansas, Florida.

The product portfolio includes a wide range of pharmaceuticals and medical supplies designed to meet the needs of hospitals, clinics, and healthcare institutions. Among its main products are diagnostic tests such as drug tests, nicotine tests, and pregnancy tests; surgical and examination gloves; surgical gowns and custom packs; endotracheal tubes; wound drainage kits; suction tubing and canisters; catheters; syringes; and IV administration sets. The company also distributes parenteral solutions, anesthetics, IV fluids, emergency medications, and hospital consumables such as underpads, surgical towels, abdominal pads, patient gowns, and caps. In addition, it supplies anesthesia circuits, HME filters, anti-embolism stockings, and personal protective equipment, including shoe covers and disposable items essential for clinical and surgical environments.

With an integrated operational structure, strong supplier partnerships, and experienced management, the company combines quality, compliance, and logistics excellence to ensure efficient delivery and customer satisfaction in the medical supply and pharmaceutical distribution industry.

Contact Tom Jones at 754-224-3111, refer to 350-511571 when inquiring.

I’m a visionary retired Dentist in Plantation who recognized a critical gap in the hand sanitization market in 2011 – the need for an FDA-approved antimicrobial solution that could match alcohol’s germ-killing efficacy while being gentle on skin. This insight sparked a determined journey through 60 different formulations to create what has now become the only patented alcohol free hands sanitizer with the only active ingredient allowed by the FDA.  My previous success was inventing the first touch free dispenser acquired by Ecolab.    

DEC 10, 2025 GAME CHANGER.  A groundbreaking independent university study on Dec 10, 2025 validated the breakthrough – proving the patented formula delivers alcohol-level antimicrobial protection previously proven that it keeps hands soft and hydrated throughout repeated daily use.  And safeHands the valuable trademark sets itself apart in a post covid market. In fact the World Health Organization (WHO) chose the name safe hands for their global hand hygiene initiation

This established company has methodically built pre-market relationships with industry giants including McKesson Medical, Henry Schein, and Medline for distribution. Major retailers including CVS, Walgreens, Target, Costco, Office Depot, and Staples have approved the product line, positioning it for full market launch pending imminent FDA approval.  Why? A U of Florida study proved the alcohol hand sanitiser is found in blood and urine.  Side effects unknown.   With $2M investment in the remaining FDA testing (we have already safeHands IS safe and effective- alcohol has yet to be proven safe) a suitor will have the ONLY alcohol free hand sanitizer approved for all markets.

The FDA knows that the safeHands story represents more than commercial success – it’s about transforming public health. By enabling frequent sanitization without skin damage, this innovation could enhance infection prevention, reduce workplace and school absenteeism, and contribute to a healthier, more productive society.

This asset sale offers the opportunity to acquire the intellectual property, trademark and institutional and retail relationships of a patent-protected solution positioned to capture significant market share in the $3.6 billion sanitization industry. The next chapter awaits a visionary buyer ready to bring this doctor’s life work to market and continue the mission of improving global wellness through innovative antimicrobial technology.  Can safeHands be the “next Purell” … only safer?   What would that ROI be for a suitor with the foundation built … plus FDA’s approval?  The precedent from alcohol to alcohol free was latex free gloves to latex (which I also participated in).

Contact Tom Jones at 754-224-3111, refer to 1248-00064 when inquiring.